Three UCSF volunteers are leading a $25-million fundraising campaign to raise funds for brain cancer treatment and research.

An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.

The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.

Former Wall Street executive Gordon Murray, a former patient UCSF, wrote a book after battling brain cancer for more than a year, knowing that he had only a few months to live when he started it.

New studies of vitamin supplements, prostate cancer risk in men and mortality in women have yielded disappointing results. Some researchers remain optimistic about identifying dietary and lifestyle interventions that are beneficial to health.

The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.